<!DOCTYPE html>
<html lang="en">
<head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta name="robots" content="noindex, nofollow">
    <title>2019 Mosaic Regeneration Inc.</title>
    <meta name="apple-mobile-web-app-capable" content="yes" />
    <meta name="apple-mobile-web-app-status-bar-style" content="default">
    <meta name="mobile-web-app-capable" content="yes" />
    <meta name="apple-mobile-web-app-title" content="Mosaic Regeneration">
    <meta name="application-name" content="Mosaic Regeneration">
    <meta name="format-detection" content="telephone=@@@@">
    <link id="favicon" rel="icon" href="favicon@@@@.ico" type="image/x-icon">
    <link rel="shortcut icon" href="favicon@@@@.ico" type="image/x-icon">
    <link href="/squadfree/css/bootstrap.min.css" rel="stylesheet" type="text/css" />
    <link href="/squadfree/font-awesome/css/font-awesome.min.css" rel="stylesheet" type="text/css" />
    <link href="/squadfree/css/animate.css" rel="stylesheet" />
    <link href="/squadfree/css/style.min.css" rel="stylesheet" />
    <style media="screen">
a,
.tp-caption a.btn:hover,
.navbar-custom ul.nav ul.dropdown-menu li a:hover {
  color: #278cc1;
}
.top-nav-collapse,
.bg-skin {
  background: #278cc1;
}
.owl-theme .owl-controls .owl-page.active span,
.owl-theme .owl-controls.clickable .owl-page:hover span,
footer {
  background-color: #278cc1;
}
.widget-avatar .avatar:hover {
  border: 5px solid #278cc1;
}
form#contact-form input:focus,form#contact-form select:focus,form#contact-form textarea:focus {
  border-color: #278cc1;
}
.btn-skin {
  color: #fff;
  background-color: #278cc1;
  border-color: #278cc1;
}
.bg-yellow {
  background-color: #cfaa00;
}
.intro {
  background: url(/static/wave355288.jpg) no-repeat top center;
}
.text-white {
  color: #fff;
}
table {
  margin-left: auto;
  margin-right: auto;
}
.border td {
  border: 1px solid #ccc;
  color: blue;
}
.accn {
  border-top: 1px solid #fff;
  border-bottom: 1px solid #fff;
}
.accn tr th {
  text-align: center;
  font-size: 110%;
  padding: 5px 10px 5px 10px;
  color: #fff;
  border-bottom: 1px solid #fff;
}
.accn tr td {
  padding: 5px 10px 5px 10px;
  color: #fff;
}
    </style>

</head>

<body id="page-top" data-spy="scroll" data-target=".navbar-custom">
    <!-- Preloader -->
    <div id="preloader">
      <div id="load"></div>
    </div>

    <nav class="navbar navbar-custom navbar-fixed-top">
        <div class="container">
            <div class="navbar-header page-scroll">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-main-collapse">
                    <i class="fa fa-bars"></i>
                </button>
                <a class="navbar-brand" href="#">
                    <h1>&nbsp;</h1>
                </a>
            </div>

            <!-- Collect the nav links, forms, and other content for toggling -->
            <div class="collapse navbar-collapse navbar-right navbar-main-collapse">
      <ul class="nav navbar-nav">
        <li><a href="#team">team</a></li>
        <li class="dropdown">
          <a href="#" class="dropdown-toggle" data-toggle="dropdown">executive summary <b class="caret"></b></a>
          <ul class="dropdown-menu">
            <li><a href="#platform">Our platform</a></li>
            <li><a href="#business">Business opportunity</a></li>
            <li><a href="#landscape">Competitive landscape</a></li>
          </ul>
        </li>
        <!--li class="dropdown">
          <a href="#" class="dropdown-toggle" data-toggle="dropdown">news <b class="caret"></b></a>
          <ul class="dropdown-menu">
            <li><a href="#press">Press Releases</a></li>
            <li><a href="#news">News Articles</a></li>
            <li><a href="#publications">Scientific Publications</a></li>
          </ul>
        </li-->
        <!--li><a href="#careers">careers</a></li-->
        <li><a href="#contact">contact</a></li>
      </ul>
            </div>
            <!-- /.navbar-collapse -->
        </div>
        <!-- /.container -->
    </nav>

    <!-- Section: intro -->
    <section id="intro" class="intro">
        <div class="slogan">
            <h2>Mosaic Regeneration &trade;</h2>
            <h4> Novel Therapies for Acute Kidney Injury </h4>
        </div>
        <div class="page-scroll">
            <a href="#team" class="btn btn-circle">
                <i class="fa fa-angle-double-down animated"></i>
            </a>
        </div>
    </section>
    <!-- /Section: intro -->

    <!-- Section: science -->
    <section id="science" class="home-section text-center">
        <div>
            <div class="container">
            <div class="row">
                <div class="col-lg-8 col-lg-offset-2">
                    <div class="section-heading">
                        <h2>Our science</h2>
                    </div>
                </div>
            </div>
            </div>
        </div>
        <div class="container">
        <div class="row">
            <div class="col-lg-8 col-lg-offset-2">
<p style="font-size:120%">Acute kidney injury (AKI) kills 90,000 people/yr in the US alone. There is no specific treatment, only supportive care. Considering its importance, there is relatively little research or progress; it is a neglected disease. AKI has many causes: sepsis, ischemia, major surgery, toxins, etc. AKI usually occurs without warning, so we need a treatment that works <em>after</em> the injury. AKI also causes or exacerbates chronic kidney disease.</p>
<p style="font-size:120%">Other groups have used various high throughput genomic and proteomic approaches to catalogue the differences between normal and injured kidneys, including at the single cell level. As far as we are aware, none of these approaches have led to any therapies for AKI.</p>
            </div>
        </div>
        </div>
    </section>
    <!-- /Section: science -->


    <!-- Section: platform -->
    <section id="platform" class="home-section text-center bg-yellow">
        <div>
            <div class="container">
            <div class="row">
                <div class="col-lg-8 col-lg-offset-2">
                    <div class="section-heading">
                        <h2 class="text-white">Our platform</h2>
                    </div>
                </div>
            </div>
            </div>
        </div>
        <div class="container">
        <div class="row">
            <div class="col-sm-3 col-md-3">
                <div class="wow fadeInDown" data-wow-delay="0.2s">
                <div class="text-box">
                    <div class="text-icon">
                        <img src="/squadfree/img/icons/white-up.png" alt="" />
                    </div>
                    <div class="text-white">
                        <h5>3D organoids</h5>
<p>We have been studying the cell biology of kidney cells for decades and have developed special expertise. In particular we have grown kidney tubule cells as 3D organoids that closely resemble the in vivo situation.</p>
                    </div>
                </div>
                </div>
            </div>
            <div class="col-sm-3 col-md-3">
                <div class="wow fadeInUp" data-wow-delay="0.3s">
                <div class="text-box">
                    <div class="text-icon">
                        <img src="/squadfree/img/icons/white-up.png" alt="" />
                    </div>
                    <div class="text-white">
                        <h5>Secreted proteins</h5>
<p>We looked for proteins that are secreted into the central lumen of injured organoids, as such proteins are likely to be important for repair.</p>
                    </div>
                </div>
                </div>
            </div>
            <div class="col-sm-3 col-md-3">
                <div class="wow fadeInDown" data-wow-delay="0.5s">
                <div class="text-box">
                    <div class="text-icon">
                        <img src="/squadfree/img/icons/white-up.png" alt="" />
                    </div>
                    <div class="text-white">
                        <h5>Mosaic pattern</h5>
<p>we value experimental group and control group test under the exact same situation and looking for factors that have mosaic pattern for biological ...</p>
                    </div>
                </div>
                </div>
            </div>
            <div class="col-sm-3 col-md-3">
                <div class="wow fadeInUp" data-wow-delay="0.6s">
                <div class="text-box">
                    <div class="text-icon">
                        <img src="/squadfree/img/icons/white-up.png" alt="" />
                    </div>
                    <div class="text-white">
                        <h5>Causal effect</h5>
<p>xxxx xxx xxxx xxx xxxx xxx xxxx xxx xxxx xxx</p>
                    </div>
                </div>
                </div>
            </div>
        </div>
        </div>
    </section>
    <!-- /Section: platform -->

    <!-- Section: business -->
      <section id="business" class="home-section">
        <div class="container">
        <div class="row">
<p style="font-size:120%">Our solution is a unique, first in class pharmaceutical, which works after the insult to the kidney. AKI has a high mortality and high incidence of long-term effects on survivors, which will justify a high cost of treatment. We expect that our treatment will be short, about two weeks. The comparable price for for similar biologics averages about $20,000 in the U.S., though less in other markets. There are about 800,000 patients in the U.S. who are diagnosed with AKI annually. Assuming $20,000 per patient and 25% market penetration = $4B U.S. sales. In the developed parts of Europe and Asia, there are about 2 million people diagnosed per year. Assuming $5,00 per patient and 25% penetration = $2.5B Europe and Asia sales. <em>Total world sales = $6.5B annually (projected).</em>
</p>
                  </div>
        </div>
    </section>
    <!-- /Section: business -->

    <!-- Section: landscape -->
      <section id="landscape" class="home-section bg-yellow">
        <div class="container">
        <div class="row">
<p style="font-size:120%">No therapies specific for AKI have been approved by the FDA or European Medicines Agency. Only a few possible competitors are known to be under development.</p>
<p>Quark Pharmaceuticals QPI-1002 (I5NP) is an siRNA targeting p53 to prevent apoptosis. This drug is in a Phase 3 trial for AKI following cardiac surgery. The drug must be given very close to the time of injury, such as occurs in AKI due to cardiac injury; this indication is a small fraction of the total AKI population.</p>
<p>AM Pharmaâ€™s Recombinant Alkaline Phosphatase for AKI due to sepsis, which is a much more common cause of AKI, failed a Phase 2 trial, as reported in November, 2018 in JAMA.</p>
                  </div>
        </div>
    </section>
    <!-- /Section: landscape -->

    <!-- Section: team -->
    <section id="team" class="home-section text-center">
        <div>
            <div class="container">
            <div class="row">
                <div class="col-lg-8 col-lg-offset-2">
                    <div class="section-heading">
                        <h2>Our team</h2>
                    </div>
                </div>
            </div>
            </div>
        </div>

        <div class="container">
<div class="row"><div class="col-lg-2 col-lg-offset-5">
    <p style="font-size:120%">We have assembled a team of scientists, innovators and advisors recognized for their pioneering work in discovering, developing and delivering new treatments to patients. We approach each day looking for powerful ways to unravel the mysteries of the human body in order to create precision therapies for the most challenging diseases. </p>
</div></div>

<!-- 1-4 -->
<div class="row"><div class="col-lg-2 col-lg-offset-5">&nbsp;</div></div>
<div class="row">
<div class="col-xs-6 col-sm-3 col-md-3"><div class="wow bounceInUp" data-wow-delay="0.1s">
<div class="team boxed-grey"><div class="inner">
    <h5>Keith Mostov</h5>
    <div class="avatar"><img src="/static/thumbnail/chenxinyuan.jpg" alt="mostov, keith" class="img-responsive img-circle" />
      <p>Acting CEO, Founder<br/>
      keith@mosaic-regeneration.com</p></div>
</div></div></div></div>
<div class="col-xs-6 col-sm-3 col-md-3"><div class="wow bounceInUp" data-wow-delay="0.3s">
<div class="team boxed-grey"><div class="inner">
    <h5>Liang Cai</h5>
    <div class="avatar"><img src="/static/thumbnail/qingxiaotian.jpg" alt="cai, liang" class="img-responsive img-circle" />
      <p>Founder<br/>
      liang@mosaic-regeneration.com</p></div>
</div></div></div></div>
<div class="col-xs-6 col-sm-3 col-md-3"><div class="wow bounceInUp" data-wow-delay="0.4s">
<div class="team boxed-grey"><div class="inner">
    <h5>Michael Donnell</h5>
    <div class="avatar"><img src="/static/thumbnail/wuxuecheng.jpg" alt="donnell, michael" class="img-responsive img-circle" />
      <p>Corporate Counsel<br/>
      MichaelODonnell@mofo.com</p></div>
</div></div></div></div>
<div class="col-xs-6 col-sm-3 col-md-3"><div class="wow bounceInUp" data-wow-delay="0.5s">
<div class="team boxed-grey"><div class="inner">
    <h5>xxxx</h5>
    <div class="avatar"><img src="/static/thumbnail/zengyuyan.jpg" alt="xxxx" class="img-responsive img-circle" />
      <p>Senior Vice President Intellectual Property, Chief Medical Officer, Board Chairman, Board Observer</p></div>
</div></div></div></div>
</div><!-- div.row -->

<div class="row"><div class="col-lg-2 col-lg-offset-5">&nbsp;</div></div>
        </div><!-- .container -->
    </section>
    <!-- /Section: team -->

    <!-- Section: contact -->
      <section id="contact" class="home-section text-center bg-yellow">
        <div>
            <div class="container">
            <div class="row">
                <div class="col-lg-8 col-lg-offset-2">
                    <div class="section-heading">
                        <h2 class="text-white">Contact us</h2>
                    </div>
                </div>
            </div>
            </div>
        </div>

        <div class="container">
        <div class="row">
<p>Mosaic Regeneration<br/>
info@mosaic-regeneration.com<br/>
415.606.6308<br/>
<br/>
600 16th St<br/>
MB GH 212B<br/>
San Francisco, CA 94158</p>
                  </div>
        </div>
    </section>
    <!-- /Section: contact -->
  
    <footer>
        <div class="container">
            <div class="row">
                <div class="col-md-12 col-lg-12">
                    <div class="wow shake" data-wow-delay="0.4s">
                    <div class="page-scroll marginbot-30">
                        <a href="#intro" id="totop" class="btn btn-circle">
                            <i class="fa fa-angle-double-up animated"></i>
                        </a>
                    </div>
                    </div>
<p>2019 &copy; All Rights Reserved &middot; Mosaic Regeneration Inc.</p>
                </div>
            </div>
        </div>
    </footer>

    <script src="/squadfree/js/jquery.min.js"></script>
    <script src="/squadfree/js/bootstrap.min.js"></script>
    <script src="/squadfree/js/jquery.easing.min.js"></script>
    <script src="/squadfree/js/jquery.scrollTo.js"></script>
    <script src="/squadfree/js/wow.min.js"></script>
    <script src="/squadfree/js/custom.js"></script>
</body>
</html>
<!--
## NEWS
#### Press Releases
#### Articles
#### Scientific Publications

## CAREERS
Please direct inquiries regarding these positions, unless noted otherwise, to:
Research Associate - CAR T  Emeryville, CA
Research Associate - Cell Line Development & Flow Cytometry Group  Emeryville, CA
-->
